The emerging role of chemokines and chemokine receptors in the biological and clinical behaviour of pituitary neuroendocrine tumours: An exploratory transcriptomic study

Documenti analoghi

• Somatostatin receptor‐linked α‐particle therapy in neuroendocrine tumours
  di: Shaunak Navalkissoor, et al.
  Pubblicazione: (2024)
• Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours
  di: Jelka Kuiper, et al.
  Pubblicazione: (2024)
• Optimal follow‐up with somatostatin receptor PET / CT imaging in patients with small intestinal neuroendocrine tumours
  di: Håkan Ohlsson, et al.
  Pubblicazione: (2024)
• Telotristat ethyl affects tumour‐fibroblast crosstalk in small intestinal neuroendocrine tumours
  di: Harry Hodgetts, et al.
  Pubblicazione: (2025)
• Using digital PCR to investigate the prevalence of KRAS variants in pituitary tumours
  di: Veronica Aran, et al.
  Pubblicazione: (2024)